Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

NCT07218913 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Hearing Loss
Metastatic Malignant Germ Cell Tumor
Metastatic Malignant Nongerminomatous Germ Cell Tumor
Metastatic Malignant Testicular Non-Seminomatous Germ Cell Tumor
Metastatic Testicular Seminoma
Stage II Testicular Cancer AJCC v8
Stage III Testicular Cancer AJCC v8

Interventions

PROCEDURE: Audiometric Test
DRUG: Cisplatin
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Sodium Thiosulfate Anhydrous

Sponsor

City of Hope Medical Center

Collaborators

National Cancer Institute (NCI)